---
title: "NewcelX wins Brazil patent for NCEL-101 manufacturing process through 2036"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292772365.md"
description: "NewcelX has secured a Brazilian patent (BR 112018010946-0) for its NCEL-101 manufacturing process, valid through November 2036. This covers cell selection and enrichment for type 1 diabetes treatment, strengthening intellectual property in the Latin American market. The program is advancing toward clinical trials following an FDA Pre-IND meeting regarding NCEL-101 combined with Eledon’s tegoprubart."
datetime: "2026-07-15T13:03:43.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292772365.md)
  - [en](https://longbridge.com/en/news/292772365.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292772365.md)
---

# NewcelX wins Brazil patent for NCEL-101 manufacturing process through 2036

-   NewcelX received a Brazilian patent covering its cell selection and enrichment manufacturing process for NCEL-101 in type 1 diabetes. \* Patent BR 112018010946-0 runs to November 2036, extending IP coverage in a large Latin American diabetes market. \* The program is moving toward clinical trials following an FDA Type B Pre-IND meeting for NCEL-101 with Eledon’s anti-CD40L antibody tegoprubart. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NLS Pharmaceutics Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607150900PRIMZONEFULLFEED9762671) on July 15, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [NCEL.US](https://longbridge.com/en/quote/NCEL.US.md)
- [ELDN.US](https://longbridge.com/en/quote/ELDN.US.md)
- [NLSP.US](https://longbridge.com/en/quote/NLSP.US.md)
- [NLSPW.US](https://longbridge.com/en/quote/NLSPW.US.md)

## Related News & Research

- [NewcelX prices USD 1.4 million private placement at USD 4.03 per share](https://longbridge.com/en/news/294517143.md)
- [NewCelX Ltd. Submits Pre-IND Package to the FDA for NCEL-101 for the Treatment of Type 1 Diabetes | NCEL Stock News](https://longbridge.com/en/news/287766589.md)
- [18:10 ETExceptional Craftsmanship Meets Arizona Roads: Find a Mercedes-Maybach in Scottsdale](https://longbridge.com/en/news/295023023.md)
- [Valterra Platinum, Pujing Chemical sign collaboration to scale up palladium-enabled MMA process](https://longbridge.com/en/news/294813403.md)
- [Temas Resources validates RCL process on SAGA ore with titanium recovery up to 90.8%](https://longbridge.com/en/news/294352567.md)